RT Journal Article
SR Electronic
T1 Measures of Behavior and Life Dynamics from Commonly Available GPS Data (DPLocate): Algorithm Development and Validation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.05.22277276
DO 10.1101/2022.07.05.22277276
A1 Rahimi-Eichi, Habiballah
A1 Coombs, Garth
A1 Onnela, Jukka-Pekka
A1 Baker, Justin T.
A1 Buckner, Randy L.
YR 2022
UL http://medrxiv.org/content/early/2022/07/10/2022.07.05.22277276.abstract
AB Locations of people moving about their lives are now commonly tracked through smartphones and wearable devices that access the Global Positioning System (GPS). Immediate measures include the estimated locations that identify visited map points and the travel paths between them. Here we introduce DPLocate, an open-source GPS data analysis pipeline designed to derive measures that abstract away from the original locations (and hence the identity of the individuals) and capture dynamics related to social, vocational, sleep, and clinical behaviors. We divide derived measures into primary and secondary. Primarily derived measures stay close to the original location data and extract deidentified metrics, including distance traveled, time spent at the main locations, and estimates of travel activity (entropy). Secondary derived measures estimate life patterns that are captured incidentally by extracting returns to the Points of Interest (POIs) in behaviorally-relevant time-bands. For example, measures of behavioral dynamics and social interactions can be gleaned by estimating the time spent in POIs across day, evening, night, and late-night time-bands. The utility of these derived measures for research is illustrated in college students and for clinical monitoring in individuals living with psychiatric disorders. Captured dynamics included behavioral transitions at the onset of the Covid-19 lockdown. Limitations of derived data are discussed, including the necessity to protect derived data from identification and possible ways in which the derived data might be misinterpreted.Competing Interest StatementJ.P.O. is a cofounder and board member of Phebe, a commercial entity that operates in digital phenotyping. J.T.B. has received consulting fees from Verily Life Sciences, as well as consulting fees and equity options from Mindstrong Health, Inc.Funding StatementThis study was funded by a generous gift from Kent and Liz Dauten, NIMH grants P50MH106435 and U01MH116925, and NIH award DP2MH103909.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of Harvard University and Institutional Review Board of Partners Healthcare both gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors https://github.com/dptools/dplocate